Arthritis, lupus and asthma data a shot in arm for AstraZeneca
AstraZeneca received a filli as 4 experimental drugs for rheumatoid arthritis, lupus and asthma showed promising results in mid-stage clinical trials.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Arthritis | Asthma | AstraZeneca | Biotechnology | Clinical Trials | Lupus | Pharmaceuticals | Rheumatoid Arthritis | Rheumatology